Search for a doctor

Michael J. Krowka, M.D.

  1. Internist
  2. Pulmonologist
Request an Appointment

Publications

  1. Burger CD, Saunders H, Hodge DO, Safford RE, Helgeson SA, Moss JE, DuBrock HM, Cartin-Ceba R, Cajigas HR, Krowka MJ. Echocardiography Screening of Consecutive Patients With Portal Hypertension Referred to Mayo Clinic for Liver Transplant Evaluation. Mayo Clin Proc. 2025 Apr; 100 (4):668-679 Epub 2024 Nov 08
    View PubMed
  2. DuBrock HM, Savale L, Sitbon O, Raevens S, Kawut SM, Fallon MB, Heimbach JK, Chadha RM, Crespo G, Ramsay MA, Krowka MJ. International liver transplantation society practice guideline update on portopulmonary hypertension. Liver Transpl. 2025 Mar 18 [Epub ahead of print]
    View PubMed
  3. Cecil CR, Moutchia J, Krowka MJ, Dubrock HM, Forde KA, Krok KL, Fallon MB, Kawut SM, Al-Naamani N. Smoking and outcomes in candidates for liver transplantation: Analysis of the Pulmonary Vascular Complications of Liver Disease 2 (PVCLD2). Liver Transpl. 2025 Mar 1; 31 (3):323-332 Epub 2024 Nov 20
    View PubMed
  4. Radosevich M, Anderson A, Teixeira M, Diwan T, Heimbach J, Taner T, Spencer P, Diaz Soto J, Reynolds A, Neff A, Krowka M, Bohman J. Practical Considerations for Extracorporeal Membrane Oxygenation Use During Orthotopic Liver Transplantation. J Cardiothorac Vasc Anesth. 2025 Mar; 39 (3):803-812 Epub 2024 Nov 26
    View PubMed
  5. Del Valle KT, Kay D, Krowka MJ, Runo JR, Sadd C, Heimbach JK, Cartin-Ceba R, Cajigas HR, Burger CD, Moss JE, DuBrock HM. The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) Exceptions. Transplant Direct. 2025 Mar; 11 (3):e1757 Epub 2025 Feb 07
    View PubMed
  6. Krowka MJ, DuBrock HM, Raevens S, Fallon MB. Unmet needs in diagnosis and management of portopulmonary hypertension: How far have we reached? Hepatology. 2024 Dec 25 [Epub ahead of print]
    View PubMed
  7. Bailey ME, Durst L, Cajigas HR, Kane GC, Krowka MJ, Kushwaha SS, McCully RB, Murphy JG, Reddy YN, Frantz RP, DuBrock HM. Using PAH-SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease. Pulm Circ. 2024 Jan; 14 (1):e12343 Epub 2024 Feb 10
    View PubMed
  8. Del Valle KT, Krowka MJ, Schinstock CA, Nath KA, Burger CD, Reddy YN, Frantz RP, Prakash YS, DuBrock HM. Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study. Pulm Circ. 2024 Jan; 14 (1):e12341 Epub 2024 Feb 10
    View PubMed
  9. Cox-Flaherty K, Moutchia J, Krowka MJ, Al-Naamani N, Fallon MB, DuBrock H, Forde KA, Krok K, Doyle MF, Kawut SM, Ventetuolo CE. Six-Minute walk distance predicts outcomes in liver transplant candidates. Liver Transpl. 2023 May 1; 29 (5):521-530 Epub 2023 Jan 25
    View PubMed
  10. DuBrock HM, Forde K, Krok K, Patel M, Al-Naamani N, Lin G, Oh JK, Fallon MB, Kawut SM, Krowka MJ. Cardiac index and hepatopulmonary syndrome in liver transplantation candidates: The pulmonary vascular complications of liver disease study. Liver Transpl. 2023 May 1; 29 (5):467-475 Epub 2023 Mar 03
    View PubMed
  11. Krowka MJ, Kamath PS. Portopulmonary hypertension: May we agree to disagree? Liver Transpl 2023 Apr 1; 29 (4):349-350 Epub 2023 Feb 03
    View PubMed
  12. Cajigas HR, Burger CD, Cartin-Ceba R, DuBrock H, Swanson K, Vargas HE, Keaveny AP, Watt KD, Krowka M. Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry. Mayo Clin Proc. 2022 Dec; 97 (12):2236-2247 Epub 2022 Nov 03
    View PubMed
  13. Del Valle KT, Krowka MJ, Heimbach JK, Taner T, DuBrock HM. Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes. Transplant Direct. 2022 Dec; 8 (12):e1410 Epub 2022 Nov 11
    View PubMed
  14. DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ, PHAR Investigators. Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry. Pulm Circ. 2022 Oct; 12 (4):e12172 Epub 2022 Dec 15
    View PubMed
  15. DuBrock HM, Reddy YN, Durst LA, Schroeder DR, Park G, Cajigas HR, Kane GC, Kushwaha SS, McCully RB, Murphy JG, Anand V, Krowka MJ, Frantz RP. The feasibility and value of assessing patient-reported outcomes in pulmonary arterial hypertension. Pulm Circ. 2022 Oct; 12 (4):e12143 Epub 2022 Oct 01
    View PubMed
  16. Kawut SM, Krowka MJ, Forde KA, Al-Naamani N, Krok KL, Patel M, Bartoli CR, Doyle M, Moutchia J, Lin G, Oh JK, Mottram CD, Scanlon PD, Fallon MB, Pulmonary Vascular Complications of Liver Disease Study Group. Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis. Eur Respir J. 2022 Aug; 60 (2) Epub 2022 Aug 04
    View PubMed
  17. Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB, Advancing Liver Therapeutic Approaches (ALTA) Consortium. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clin Gastroenterol Hepatol. 2022 Aug; 20 (8):1636-1662.e36 Epub 2021 July 15
    View PubMed
  18. DuBrock HM, Del Valle KT, Krowka MJ. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception. Liver Transpl. 2022 Jul; 28 (7):1224-1230 Epub 2022 Apr 21
    View PubMed
  19. Aragon Pinto C, Iyer V, Almodallal YA, Albitar H, Dubrock H, Cajigas H, Heimbach JK, Rosen CB, Watt K, Taner T, Nyberg S, Vargas H, Cartin-Ceba R, Keaveny AP, Krowka M, Gallo de Moraes A. ICU and Hospital Outcomes in Patients with Hepatopulmonary Syndrome Undergoing Liver Transplantation. Lung. 2022 Feb; 200 (1):5-10 Epub 2022 Jan 10
    View PubMed
  20. Aragon Pinto C, Iyer VN, Albitar HAH, Anderson A, Cajigas H, Simonetto DA, Krowka MJ, DuBrock HM, Gallo de Moraes A. Outcomes of liver transplantation in patients with hepatopulmonary syndrome in the pre and post-MELD eras: A systematic review. Respir Med Res. 2021 Nov; 80:100852 Epub 2021 July 30
    View PubMed
  21. Cartin-Ceba R, Burger C, Swanson K, Vargas H, Aqel B, Keaveny AP, Heimbach J, Taner T, Nyberg S, Rosen C, Cajigas H, DuBrock H, Krowka MJ. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension. Transplantation. 2021 Oct 1; 105 (10):2283-2290
    View PubMed
  22. Abu Rmilah A, Fencl R, Watt K, Krowka M, Wiesner R, Murray D, Nyberg S, Leise M. Association of alpha 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation. Transplantation. 2021 Jul 1; 105 (7):1576-1584
    View PubMed
  23. DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ. Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry. Pulm Circ. 2021 Jul-Sep; 11 (3):20458940211020913 Epub 2021 May 17
    View PubMed
  24. Murray JD, Willrich MA, Krowka MJ, Bobr A, Murray DL, Halling KC, Graham RP, Snyder MR. Liquid Chromatography-Tandem Mass Spectrometry-Based alpha1-Antitrypsin (AAT) Testing. Am J Clin Pathol. 2021 Mar 15; 155 (4):547-552
    View PubMed
  25. Al-Naamani N, Krowka MJ, Forde KA, Krok KL, Feng R, Heresi GA, Dweik RA, Bartolome S, Bull TM, Roberts KE, Austin ED, Hemnes AR, Patel MJ, Oh JK, Lin G, Doyle MF, Denver N, Andrew R, MacLean MR, Fallon MB, Kawut SM, Pulmonary Vascular Complications of Liver Disease Study Group. Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2). Hepatology. 2021 Feb; 73 (2):726-737 Epub 2020 Sept 29
    View PubMed
  26. Hasan Albitar HA, Van Houten H, Sangaralingham LR, Knoedler M, Almodallal Y, Alkurashi AK, De Moraes AG, Cajigas H, DuBrock H, Warad D, Demirel N, Krowka M, Brinjikji W, Iyer VN. Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb; 5(1):55-64. Epub 2020 Nov 20.
    View PubMed
  27. DuBrock HM, Cartin-Ceba R, Channick RN, Kawut SM, Krowka MJ. Sex Differences in Portopulmonary Hypertension. Chest. 2021 Jan; 159 (1):328-336 Epub 2020 Aug 13
    View PubMed
  28. DuBrock HM, Runo JR, Sadd CJ, Burger CD, Cartin-Ceba R, Rosen CB, Taner T, Nyberg SL, Heimbach JK, Findlay JY, Krowka MJ. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure >/=35 mm Hg. Transplant Direct. 2020 Dec; 6 (12):e630 Epub 2020 Nov 10
    View PubMed
  29. DuBrock HM, Krowka MJ. The Myths and Realities of Portopulmonary Hypertension. Hepatology. 2020 Oct; 72 (4):1455-1460
    View PubMed
  30. DuBrock HM, Krowka MJ. Bubble Trouble in COVID-19. Am J Respir Crit Care Med 2020 Oct 1; 202 (7):926-928
    View PubMed
  31. DuBrock HM, Krowka MJ, Krok K, Forde K, Mottram C, Scanlon P, Al-Naamani N, Patel M, McCormick A, Fallon MB, Kawut SM. Prevalence and Impact of Restrictive Lung Disease in Liver Transplant Candidates. Liver Transpl. 2020 Aug; 26 (8):989-999 Epub 2020 July 09
    View PubMed
  32. Albitar HAH, Almodallal Y, Gallo De Moraes A, O'Brien E, Choby GW, Pruthi RK, Stokken JK, Kamath PS, Cajigas HR, DuBrock HM, Krowka MJ, Iyer VN. Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia-Related Bleeding and High-Output Cardiac Failure: Significant Inter-Individual Variability in the Need for Maintenance Therapy. Mayo Clin Proc. 2020 Aug; 95 (8):1604-1612
    View PubMed
  33. Rochon ER, Krowka MJ, Bartolome S, Heresi GA, Bull T, Roberts K, Hemnes A, Forde KA, Krok KL, Patel M, Lin G, McNeil M, Al-Naamani N, Roman BL, Yu PB, Fallon MB, Gladwin MT, Kawut SM. BMP9/10 in Pulmonary Vascular Complications of Liver Disease. Am J Respir Crit Care Med 2020 Jun 15; 201 (12):1575-1578
    View PubMed
  34. Preston IR, Burger CD, Bartolome S, Safdar Z, Krowka M, Sood N, Ford HJ, Battarjee WF, Chakinala MM, Gomberg-Maitland M, Hill NS. Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial. J Heart Lung Transplant. 2020 May; 39 (5):464-472 Epub 2020 Jan 21
    View PubMed
  35. Krowka MJ. Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease. Clin Liver Dis (Hoboken). 2020 Feb; 15 (Suppl 1):S13-S24 Epub 2020 Mar 02
    View PubMed
  36. Cartin-Ceba R, Krowka MJ. Pulmonary Complications of Portal Hypertension. Clin Liver Dis. 2019 Nov; 23 (4):683-711 Epub 2019 Aug 09
    View PubMed
  37. Anand V, Frantz RP, DuBrock H, Kane GC, Krowka M, Yanagisawa R, Sandhu GS. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience. Mayo Clin Proc Innov Qual Outcomes. 2019 Sep; 3 (3):311-318 Epub 2019 Aug 23
    View PubMed
  38. Kawut SM, Ellenberg SS, Krowka MJ, Goldberg D, Vargas H, Koch D, Sharkoski T, Al-Naamani N, Fox A, Brown R, Levitsky J, Oh JK, Lin G, Song N, Mottram C, Doyle MF, Kaplan DE, Gupta S, Fallon MB. Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Liver Transpl. 2019 Aug; 25 (8):1155-1164 Epub 2019 May 30
    View PubMed
  39. Iyer VN, Saberi B, Heimbach JK, Larson JJ, Raghavaiah S, Ditah I, Swanson K, Kamath PS, Watt KD, Taner T, Krowka MJ, Leise MD. Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States. Transplantation. 2019 Jul; 103 (7):1418-1424
    View PubMed
  40. Sitbon O, Bosch J, Cottreel E, Csonka D, de Groote P, Hoeper MM, Kim NH, Martin N, Savale L, Krowka M. Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial. Lancet Respir Med. 2019 Jul; 7 (7):594-604 Epub 2019 June 06
    View PubMed
  41. DuBrock HM, Salgia RJ, Sussman NL, Bartolome SD, Kadry Z, Mulligan DC, Jenkins S, Lackore K, Channick RN, Kawut SM, Krowka MJ. Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes. Transplant Direct. 2019 Jun; 5 (6):e456 Epub 2019 May 22
    View PubMed
  42. Krowka MJ. Treatment of Portopulmonary Hypertension With Macitentan in Patients With Cirrhosis. Gastroenterol Hepatol (N Y). 2019 Feb; 15 (2):108-110
    View PubMed
  43. AbuHalimeh B, Krowka MJ, Tonelli AR. Treatment Barriers in Portopulmonary Hypertension. Hepatology. 2019 Jan; 69 (1):431-443 Epub 2018 Dec 18
    View PubMed
  44. Forde KA, Fallon MB, Krowka MJ, Sprys M, Goldberg DS, Krok KL, Patel M, Lin G, Oh JK, Mottram CD, Scanlon PD, Kawut SM, Pulmonary Vascular Complications of Liver Disease 2 Study Group. Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation. Hepatology. 2019 Jan; 69 (1):270-281 Epub 2018 Dec 18
    View PubMed
  45. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019 Jan; 53 (1) Epub 2019 Jan 24
    View PubMed
  46. Fuhrmann V, Krowka M. Hepatopulmonary syndrome. J Hepatol. 2018 Sep; 69 (3):744-745 Epub 2018 June 28
    View PubMed
  47. Cartin-Ceba R, Halank M, Ghofrani HA, Humbert M, Mattson J, Fritsch A, Krowka M. Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies. Pulm Circ. 2018 Apr-Jun; 8 (2):2045894018769305 Epub 2018 Mar 22
    View PubMed
  48. Rodriguez-Roisin R, Krowka MJ, Agusti A. Hepatopulmonary Disorders: Gas Exchange and Vascular Manifestations in Chronic Liver Disease. Compr Physiol. 2018 Mar 25; 8 (2):711-729
    View PubMed
  49. Gupta S, Krowka MJ. Hepatopulmonary syndrome. CMAJ. 2018 Feb 26; 190 (8):E223
    View PubMed
  50. Iyer VN, Apala DR, Pannu BS, Kotecha A, Brinjikji W, Leise MD, Kamath PS, Misra S, Begna KH, Cartin-Ceba R, DuBrock HM, Krowka MJ, O'Brien EK, Pruthi RK, Schroeder DR, Swanson KL. Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding. Mayo Clin Proc. 2018 Feb; 93 (2):155-166 Epub 2018 Jan 24
    View PubMed
  51. DuBrock HM, Krowka MJ, Forde KA, Krok K, Patel M, Sharkoski T, Sprys M, Lin G, Oh JK, Mottram CD, Scanlon PD, Fallon MB, Kawut SM. Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver Transplant. Chest. 2018 Feb; 153 (2):414-426 Epub 2017 Oct 05
    View PubMed
  52. Segraves JM, Cartin-Ceba R, Leise MD, Krowka MJ. Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works. Hepatol Res. 2018 Feb; 48 (3):E340-E346 Epub 2017 Aug 31
    View PubMed
  53. Iyer VN, Brinjikji W, Apala D, Pannu BS, Kotecha A, Leise MD, Kamath PS, Misra S, Lanzino G, Krowka MJ, Wood CP, Swanson KL. Impact of Age on Outcomes in Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia. Adv Hematol. 2018; 2018:4798425 Epub 2018 Feb 11
    View PubMed
  54. DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation. 2017 Jul; 101 (7):1609-1615
    View PubMed
  55. DeMartino ES, Krowka MJ. Pulmonary Vascular Complications of Liver Disease. Int Anesthesiol Clin. 2017 Spring; 55 (2):67-80
    View PubMed
  56. DeMartino ES, Cartin-Ceba R, Findlay JY, Heimbach JK, Krowka MJ. Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation. Transplantation. 2017 Jan; 101: (1)101-106.
    View PubMed
  57. Iyer VN, Brinjikji W, Pannu BS, Apala DR, Lanzino G, Cloft HJ, Misra S, Krowka MJ, Wood CP, Swanson KL. Effect of Center Volume on Outcomes in Hospitalized Patients With Hereditary Hemorrhagic Telangiectasia. Mayo Clin Proc. 2016 Dec; 91 (12):1753-1760 Epub 2016 Nov 01
    View PubMed
  58. Brinjikji W, Wood CP, Lanzino G, Cloft HJ, Misra S, Kallmes DF, Kamath P, Pruthi RK, Krowka MJ, Swanson KL, Iyer VN. High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States. Ann Am Thorac Soc. 2016 Sep; 13 (9):1505-11
    View PubMed
  59. Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, Sitbon O, Sokol RJ. International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation. 2016 Jul; 100 (7):1440-52
    View PubMed
  60. Fussner LA, Krowka MJ. Current Approach to the Diagnosis and Management of Portopulmonary Hypertension. Curr Gastroenterol Rep. 2016 Jun; 18 (6):29
    View PubMed
  61. Krowka MJ. Cardiopulmonary examination. Clin Liver Dis (Hoboken). 2016 May; 7 (5):116-118 Epub 2016 May 27
    View PubMed
  62. Lyle MA, Fenstad ER, McGoon MD, Frantz RP, Krowka MJ, Kane GC, Swanson KL. Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia. Chest. 2016 Feb; 149 (2):362-371 Epub 2016 Jan 12
    View PubMed
  63. Rodriguez-Roisin R, Bartolome SD, Huchon G, Krowka MJ. Inflammatory bowel diseases, chronic liver diseases and the lung. Eur Respir J. 2016 Feb; 47 (2):638-50 Epub 2016 Jan 21
    View PubMed
  64. Fussner LA, Iyer VN, Cartin-Ceba R, Lin G, Watt KD, Krowka MJ. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival. Liver Transpl. 2015 Nov; 21: (11)1355-64.
    View PubMed
  65. DuBrock HM, Channick RN, Krowka MJ. What's new in the treatment of portopulmonary hypertension? Expert Review Of Gastroenterology & Hepatology. 2015 Jul; 9: (7)983-92.
    View PubMed
  66. Singh S, Swanson KL, Hathcock MA, Kremers WK, Pallanch JF, Krowka MJ, Kamath PS. Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index. J Hepatol. 2014 Jul; 61(1):124-31. Epub 2014 Mar 06.
    View PubMed
  67. Cartin-Ceba R, Krowka MJ. Portopulmonary hypertension. Clin Liver Dis. 2014 May; 18(2):421-38. Epub 2014 Feb 25.
    View PubMed
  68. Batra S, Machicao VI, Bynon JS, Mehta S, Tanikella R, Krowka MJ, Zacks S, Trotter J, Roberts KE, Brown RS, Kawut SM, Fallon MB. The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. Liver Transpl. 2014; 20(6):705-12.
    View PubMed
  69. Carey EJ, Iyer VN, Nelson DR, Nguyen JH, Krowka MJ. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency-related cirrhosis. Liver Transpl. 2013 Dec; 19: (12)1370-6.
    View PubMed
  70. Cartin-Ceba R, Swanson KL, Krowka MJ. Pulmonary arteriovenous malformations. Chest. 2013 Sep; 144 (3):1033-1044
    View PubMed
  71. Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol. 2013 Aug; 59 (2):367-74 Epub 2013 Apr 01
    View PubMed
  72. Iyer VN, Swanson KL, Cartin-Ceba R, Dierkhising RA, Rosen CB, Heimbach JK, Wiesner RH, Krowka MJ. Hepatopulmonary syndrome: favorable outcomes in the MELD exception era. Hepatology. 2013 Jun; 57: (6)2427-35.
    View PubMed
  73. Patel SM, Sekiguchi H, Reynolds JP, Krowka MJ. Pulmonary alveolar proteinosis. Can Respir J. 2012 Jul-Aug; 19 (4):243-5
    View PubMed
  74. Krowka MJ, Miller DP, Barst RJ, Taichman D, Dweik RA, Badesch DB, McGoon MD. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest. 2012 Apr; 141 (4):906-915 Epub 2011 July 21
    View PubMed
  75. Krowka MJ. Portopulmonary hypertension. Semin Respir Crit Care Med. 2012 Feb; 33 (1):17-25 Epub 2012 Mar 23
    View PubMed
  76. Rahaghi FF, Sandhaus RA, Strange C, Hogarth DK, Eden E, Stocks JM, Krowka MJ, Stoller JK. The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2012; 9(4):352-8.
  77. Krowka MJ, Rodriguez-Roisin R. Portopulmonary hypertension: A consequence of portal hypertension. European Respiratory Monograph. 2012; 57:58-70.
  78. Talwalkar JA, Swanson KL, Krowka MJ, Andrews JC, Kamath PS. Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. Gastroenterology. 2011 Nov; 141 (5):1673-9 Epub 2011 June 30
    View PubMed
  79. Krowka MJ. Management of pulmonary complications in pretransplant patients. Clin Liver Dis. 2011 Nov; 15(4):765-77.
    View PubMed
  80. Li Y, Krowka MJ, Qi Y, Katzmann JA, Song Y, Li Y, Mandrekar SJ, Yang P. Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. J Thorac Oncol. 2011 Feb; 6 (2):291-5
    View PubMed
  81. Cartin-Ceba R, Swanson K, Iyer V, Wiesner RH, Krowka MJ. Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Chest. 2011 Jan; 139: (1)109-14.
    View PubMed
  82. Tanikella R, Kawut SM, Brown RS Jr, Krowka MJ, Reinen J, Dinasarapu CR, Trotter JF, Roberts KE, Mohd MA, Arnett DK, Fallon MB. Health-related quality of life and survival in liver transplant candidates. Liver Transpl. 2010 Feb; 16(2):238-45.
    View PubMed
  83. Roberts KE, Kawut SM, Krowka MJ, Brown RS, Trotter JF, Shah V, Peter I, Tighiouart H, Mitra N, Handorf E, Knowles JA, Zacks S, Fallon MB. Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology. 2010; 139(1).
  84. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009 Jun 30; 54 (1 Suppl):S43-S54
    View PubMed
  85. Roberts KE, Fallon MB, Krowka MJ, Benza RL, Knowles JA, Badesch DB, Brown RS Jr, Taichman DB, Trotter J, Zacks S, Horn EM, Kawut SM, Pulmonary Vascular Complications of Liver Disease Study Group. Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest. 2009 Jun; 135 (6):1470-1475 Epub 2009 Jan 13
    View PubMed
  86. Peng T, Zamanian R, Krowka MJ, Benza RL, Roberts KE, Taichman DB, Rybak D, Trotter JF, Brown RS Jr, Fallon MB, Kawut SM, Pulmonary Vascular Complications of Liver Disease Study Group. Plasma levels of S100A4 in portopulmonary hypertension. Biomarkers. 2009 May; 14(3):156-60.
    View PubMed
  87. Roberts KE, Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, Tighiouart H, Knowles JA, Rabinowitz D, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Kawut SM, Pulmonary Vascular Complications of Liver Disease Study Group. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med. 2009 May 1; 179(9):835-42. Epub 2009 Feb 12.
    View PubMed
  88. Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation. 2008 Nov 27; 86 (10):1384-8
    View PubMed
  89. Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant. 2008 Nov; 8 (11):2445-53 Epub 2008 Sept 08
    View PubMed
  90. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, Kaplowitz N, Forman L, Wille K, Kawut SM, Pulmonary Vascular Complications of Liver Disease Study Group. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008 Oct; 135(4):1168-75. Epub 2008 Jun 20.
    View PubMed
  91. Iqbal CW, Krowka MJ, Pham TH, Freese DK, El Youssef M, Ishitani MB. Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease. J Pediatr Surg. 2008 Oct; 43: (10)1813-20.
    View PubMed
  92. Porres-Aguilar M, Zuckerman MJ, Figueroa-Casas JB, Krowka MJ. Portopulmonary hypertension: state of the art. Ann Hepatol. 2008 Oct-Dec; 7(4):321-30.
    View PubMed
  93. Rybak D, Fallon MB, Krowka MJ, Brown RS Jr, Reinen J, Stadheim L, Faulk D, Nielsen C, Al-Naamani N, Roberts K, Zacks S, Perry T, Trotter J, Kawut SM, Pulmonary Vascular Complications of Liver Disease Study Group. Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation. Liver Transpl. 2008 Sep; 14(9):1357-65.
    View PubMed
  94. Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS Jr, Fallon MB, Pulmonary Vascular Complications of Liver Disease Study Group. Clinical risk factors for portopulmonary hypertension. Hepatology. 2008 Jul; 48(1):196-203.
    View PubMed
  95. Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med. 2008 May 29; 358(22):2378-87.
    View PubMed
  96. Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, Wampfler JA, Thibodeau SN, Katzmann JA, Allen MS, Midthun DE, Marks RS, de Andrade M. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med. 2008 May 26; 168 (10):1097-103
    View PubMed
  97. Swanson KL, Utz JP, Krowka MJ. Doppler echocardiography-right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension. Med Sci Monit. 2008 Apr; 14(4):CR177-82.
    View PubMed
  98. Swanson KL, Krowka MJ. Screen for portopulmonary hypertension, especially in liver transplant candidates. Cleve Clin J Med. 2008 Feb; 75 (2):121-2, 125-30, 133 passim
    View PubMed
  99. Ammash NM, McGoon MD, Shub A, Seward JB, Oh JK, Krowka MJ, Pellikka PA, Moon BS, Bailey KR, Wood CM, Tajik AJ. Exercise-echocardiography-derived pulmonary artery pressure slope in borderline and mild to moderate pulmonary arterial hypertension. Clin Med: Cardiol. 2008; 2:235-44.
  100. Ryu JH, Krowka MJ, Pellikka PA, Swanson KL, McGoon MD. Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc. 2007 Mar; 82(3):342-50.
    View PubMed
  101. Golbin JM, Krowka MJ. Portopulmonary hypertension. Clin Chest Med. 2007 Mar; 28: (1)203-18, ix.
    View PubMed
  102. Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl. 2006 Dec; 12(12 Suppl 3):S105-7.
    View PubMed
  103. Krowka MJ, Fallon MB, Mulligan DC, Gish RG. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension. Liver Transpl. 2006 Dec; 12(12 Suppl 3):S114-6.
    View PubMed
  104. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology. 2006 Dec; 44 (6):1502-10
    View PubMed
  105. Krowka MJ. Evolving dilemmas and management of portopulmonary hypertension. Semin Liver Dis. 2006 Aug; 26 (3):265-72
    View PubMed
  106. Parambil JG, Gersh BJ, Knight MZ, Krowka MJ, Ryu JH. Bronchogenic cyst causing atrial fibrillation by impinging the right inferior pulmonary vein. Am J Med Sci. 2006 Jun; 331 (6):336-8
    View PubMed
  107. Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin Chest Med. 2005 Dec; 26(4):587-97, vi.
    View PubMed
  108. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. Chest. 2005 Dec; 128(6 Suppl):616S-617S.
    View PubMed
  109. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest. 2005 Oct; 128 (4):2393-9
    View PubMed
  110. Shapiro BP, Sprung J, Scott K, Arendt K, Krowka MJ, Afessa B. Cardiovascular collapse induced by position-dependent pulmonary vein occlusion in a patient with fibrosing mediastinitis. Anesthesiology. 2005 Sep; 103 (3):661-3
    View PubMed
  111. Yang P, Bamlet WR, Sun Z, Ebbert JO, Aubry MC, Krowka MJ, Taylor WR, Marks RS, Deschamps C, Swensen SJ, Wieben ED, Cunningham JM, Melton LJ, de Andrade M. Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest. 2005 Jul; 128(1):445-52.
    View PubMed
  112. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology. 2005 May; 41: (5)1122-9.
    View PubMed
  113. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB, ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J. 2004 Nov; 24(5):861-80.
    View PubMed
  114. Chaowalit N, Pellikka PA, Decker PA, Aubry MC, Krowka MJ, Ryu JH, Vassallo R. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc. 2004 Oct; 79: (10)1269-75.
    View PubMed
  115. Nadrous HF, Krowka MJ, Myers JL, Allen MS, Sabri AN. Tracheal myxoma: a rare benign tracheal tumor. Mayo Clin Proc. 2004 Jul; 79 (7):931-3
    View PubMed
  116. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004 Jun 16; 43(12 Suppl S):40S-47S.
    View PubMed
  117. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004 May 1; 363(9419):1461-8.
    View PubMed
  118. Nadrous HF, Krowka MJ, McClure RF, Tefferi A, Lim KG. Agnogenic myeloid metaplasia with pleural extramedullary leukemic transformation. Leuk Lymphoma. 2004 Apr; 45 (4):815-8
    View PubMed
  119. Yen KT, Lee AS, Krowka MJ, Burger CD. Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment. Clin Chest Med. 2004 Mar; 25(1):189-201.
    View PubMed
  120. Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, Pardo M Jr, Marotta P, Uemoto S, Stoffel MP, Benson JT. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl. 2004 Feb; 10(2):174-82.
    View PubMed
  121. Krowka MJ. Portopulmonary hypertension: screening and diagnosis. Advances in Pulmonary Hypertension. 2004; 3:5-8.
  122. Krowka MJ. The hepatopulmonary and portopulmonary hypertension syndromes. Falk Symposium. 2004; 137:321-4.
  123. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology. 2003 Jan; 37(1):192-7.
    View PubMed
  124. Yen KT, Krowka MJ, Lee AS, Kramer DJ, Burger CD. Liver and lung: how to manage portopulmonary hypertension: despite high pulmonary artery pressure, ECG findings may be normal. J Crit Illn. 2002 Oct; 17(10):401-6.
  125. Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002 Sep 1; 166 (5):641-5
    View PubMed
  126. Yen KT, Krowka MJ, Lee AS, Kramer DJ, Burger CD. Liver and lung: hepatopulmonary syndrome: recognizing the clinical features and selecting the right studies. J Crit Illn. 2002 Aug; 17(8):309-15.
  127. Krowka MJ. Hepatopulmonary Syndrome and Portopulmonary Hypertension. Curr Treat Options Cardiovasc Med. 2002 Jun; 4 (3):267-273
    View PubMed
  128. Swanson KL, Krowka MJ. Arterial oxygenation associated with portopulmonary hypertension. Chest. 2002 Jun; 121 (6):1869-75
    View PubMed
  129. Krowka MJ. Hepatopulmonary Syndrome and Portopulmonary Hypertension. Curr Treat Options Gastroenterol. 2001 Dec; 4 (6):539-545
    View PubMed
  130. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest. 2001 Sep; 120 (3):801-8
    View PubMed
  131. Krowka MJ. Hepatopulmonary syndrome and extrahepatic vascular abnormalities. Liver Transpl. 2001 Jul; 7: (7)656-7.
    View PubMed
  132. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest. 2000 Sep; 118 (3):615-24
    View PubMed
  133. Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, Waldron JA, Ryu JH. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am J Epidemiol. 2000 Aug 15; 152 (4):307-15
    View PubMed
  134. Krowka MJ. Hepatopulmonary syndrome: recent literature (1997 to 1999) and implications for liver transplantation. Liver Transpl. 2000 Jul; 6 (4 Suppl 1):S31-5
    View PubMed
  135. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RAF. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000 Jul; 6(4):443-50.
    View PubMed
  136. Kim WR, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP, Wiesner RH. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl. 2000 Jul; 6: (4)453-8.
    View PubMed
  137. Krowka MJ. Pulmonary hypertension: diagnostics and therapeutics. Mayo Clin Proc. 2000 Jun; 75: (6)625-30.
    View PubMed
  138. Krowka MJ, Edwards WD. A spectrum of pulmonary vascular pathology in portopulmonary hypertension. Liver Transpl. 2000 Mar; 6(2):241-2.
    View PubMed
  139. Krowka MJ. Hepatopulmonary syndromes. Gut. 2000 Jan; 46 (1):1-4
    View PubMed
  140. Krowka MJ. Pulmonary manifestations of chronic liver disease. Clinical Pulmonary Medicine. 2000; 7(1):24-29.
  141. Krowka MJ. Pulmonary hypertension: an update of diagnostic and therapeutics. Mayo Clin Proc. 2000; 6:453-8.
  142. Findlay JY, Plevak DJ, Krowka MJ, Sack EM, Porayko MK. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transpl Surg. 1999 Sep; 5(5):362-5.
    View PubMed
  143. Findlay JY, Harrison BA, Plevak DJ, Krowka MJ. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension. Liver Transpl Surg. 1999 Sep; 5 (5):381-7
    View PubMed
  144. Krowka MJ, Wiseman GA, Steers JL, Wiesner RH. Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation. Liver Transpl Surg. 1999 Sep; 5(5):451-3.
    View PubMed
  145. Krowka MJ, Frantz RP, McGoon MD, Severson C, Plevak DJ, Wiesner RH. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology. 1999 Sep; 30(3):641-8.
    View PubMed
  146. Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999 Sep; 107 (3):262-7
    View PubMed
  147. Yang P, Wentzlaff KA, Katzmann JA, Marks RS, Allen MS, Lesnick TG, Lindor NM, Myers JL, Wiegert E, Midthun DE, Thibodeau SN, Krowka MJ. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev. 1999 May; 8 (5):461-5
    View PubMed
  148. Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology. 1998 Feb; 114(2):305-10.
    View PubMed
  149. Krowka MJ, Alpha1-antitrypsin deficiency n deficiency registry study group. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. Am J Respir Crit Care Med. 1998; 158:49-59.
    View PubMed
  150. Krowka MJ, Porayko MK, Plevak DJ, Pappas SC, Steers JL, Krom RA, Wiesner RH. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc. 1997 Jan; 72 (1):44-53
    View PubMed
  151. Krowka MJ. Pathophysiology of arterial hypoxemia in advanced liver disease. Liver Transpl Surg. 1996 Jul; 2 (4):308-12
    View PubMed
  152. Castro M, Krowka MJ, Schroeder DR, Beck KC, Plevak DJ, Rettke SR, Cortese DA, Wiesner RH. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc. 1996 Jun; 71 (6):543-51
    View PubMed
  153. Castro M, Krowka MJ. Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med. 1996 Mar; 17(1):35-48.
    View PubMed
  154. Krowka MJ. Recent pulmonary observations in alpha 1-antitrypsin deficiency, primary biliary cirrhosis, chronic hepatitis C, and other hepatic problems. Clin Chest Med. 1996 Mar; 17 (1):67-82
    View PubMed
  155. Poterucha JJ, Krowka MJ, Dickson ER, Cortese DA, Stanson AW, Krom RA. Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology. 1995 Jan; 21: (1)96-100.
    View PubMed
  156. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest. 1994 May; 105 (5):1528-37
    View PubMed
  157. Krowka MJ. A registry of patients with severe deficiency of alpha1-antitrypsin: design and methods. Chest. 1994; 196:1223-32.
  158. Krowka MJ. Clinical management of hepatopulmonary syndrome. Semin Liver Dis. 1993 Nov; 13: (4)414-22.
    View PubMed
  159. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest. 1993 Aug; 104 (2):515-21
    View PubMed
  160. Afessa B, Gay PC, Plevak DJ, Swensen SJ, Patel HG, Krowka MJ. Pulmonary complications of orthotopic liver transplantation. Mayo Clin Proc. 1993 May; 68 (5):427-34
    View PubMed
  161. Krowka MJ. Hepatopulmonary syndrome. Transplant Proc. 1993 Apr; 25(2):1746-7.
    View PubMed
  162. Plevak D, Krowka M, Rettke S, Dunn W, Southorn P. Successful liver transplantation in patients with mild to moderate pulmonary hypertension. Transplant Proc. 1993 Apr; 25(2):1840.
    View PubMed
  163. Krowka MJ, Dickson ER, Wiesner RH, Krom RA, Atkinson B, Atkinson B, Cortese DA. A prospective study of pulmonary function and gas exchange following liver transplantation. Chest. 1992 Oct; 102 (4):1161-6
    View PubMed
  164. Perrella MA, Edell ES, Krowka MJ, Cortese DA, Burnett JC Jr. Endothelium-derived relaxing factor in pulmonary and renal circulations during hypoxia. Am J Physiol. 1992 Jul; 263 (1 Pt 2):R45-50
    View PubMed
  165. Krowka MJ, Grambsch PM, Edell ES, Cortese DA, Dickson ER. Primary biliary cirrhosis: relation between hepatic function and pulmonary function in patients who never smoked. Hepatology. 1991 Jun; 13(6):1095-100.
    View PubMed
  166. Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest. 1990 May; 97 (5):1165-70
    View PubMed
  167. Krowka MJ, Staats BA, Hoagland HC. A prospective study of airway reactivity before bone marrow transplantation. Mayo Clin Proc. 1990 Jan; 65 (1):5-12
    View PubMed
  168. Krowka MJ, Cortese DA. Pulmonary aspects of liver disease and liver transplantation. Clin Chest Med. 1989 Dec; 10(4):593-616.
    View PubMed
  169. Edell ES, Cortese DA, Krowka MJ, Rehder K. Severe hypoxemia and liver disease. Am Rev Respir Dis. 1989 Dec; 140: (6)1631-5.
    View PubMed
  170. Krowka MJ, Enright PL, Rodarte JR, Hyatt RE. Effect of effort on measurement of forced expiratory volume in one second. Am Rev Respir Dis. 1987 Oct; 136(4):829-33.
    View PubMed
  171. Krowka MJ, Pairolero PC, Trastek VF, Payne WS, Bernatz PE. Cardiac dysrhythmia following pneumonectomy. Clinical correlates and prognostic significance. Chest. 1987 Apr; 91(4):490-5.
    View PubMed
  172. Krowka MJ, Cortese DA. Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate. Mayo Clin Proc. 1987 Mar; 62(3):164-73.
    View PubMed
  173. Krowka MJ, Cortese DA. Pulmonary complications of hepatic cirrhosis. Pract Cardiol. 1986; 3:150-160.
  174. Krowka MJ, Cortese DA. Pulmonary aspects of chronic liver disease and liver transplantation. Mayo Clin Proc. 1985 Jun; 60(6):407-18.
    View PubMed
  175. Krowka MJ, Rosenow EC 3rd, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest. 1985 Feb; 87(2):237-46.
    View PubMed
  176. Krowka MJ, Breuer RI, Kehoe TJ. Azathioprine-associated pulmonary dysfunction. Chest. 1983 Apr; 83(4):696-8.
    View PubMed
  177. Krowka MJ, Peak OC. Admission data: their use in health planning, legislative presentations, and premedical programs. J Med Educ. 1981 Sep; 56(9 Pt 1):777-9.
    View PubMed
  178. Krowka MJ, Peck OC. Relating health planning concepts to medical students. J Med Educ. 1979 Dec; 54(12):946-7.
    View PubMed
  179. Peck OC, Krowka MJ, May JR. Feedback from admission committees to applicant interviewers. J Med Educ. 1978 Aug; 53(8):680-1.
    View PubMed
  180. Krowka MJ, Schwartz JP. An empirical approach to projecting regional blood need. Transfusion (Paris). 1977 Sep-Oct; 17: (5)479-83.
    View PubMed
PST-20221901